Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens

<p>Abstract</p> <p>Background</p> <p>To develop effective strategies in cancer chemoprevention, an increased understanding of endogenous biochemical mediators that block metastatic processes is critically needed. Dietary lipids and non-steroidal anti-inflammatory drugs...

Full description

Bibliographic Details
Main Authors: Wood Paul L, Khan M, Smith Tara, Goodenowe Dayan B
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://www.lipidworld.com/content/10/1/214
_version_ 1831728983718232064
author Wood Paul L
Khan M
Smith Tara
Goodenowe Dayan B
author_facet Wood Paul L
Khan M
Smith Tara
Goodenowe Dayan B
author_sort Wood Paul L
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>To develop effective strategies in cancer chemoprevention, an increased understanding of endogenous biochemical mediators that block metastatic processes is critically needed. Dietary lipids and non-steroidal anti-inflammatory drugs (NSAIDs) have a published track record of providing protection against gastrointestinal malignancies. In this regard, we examined the effects of membrane plasmalogens and ibuprofen on regulation of cellular levels of diamines, polyamine mediators that are augmented in cancer cells. For these studies we utilized Chinese hamster ovary (CHO) cells and NRel-4 cells, a CHO cell line with defective plasmalogen synthesis.</p> <p>Results</p> <p>NRel-4 cells, which possess cellular plasmalogen levels that are 10% of control CHO cells, demonstrated 2- to 3-fold increases in cellular diamine levels. These diamine levels were normalized by plasmalogen replacement and significantly reduced by ibuprofen. In both cases the mechanism of action appears to mainly involve increased diamine efflux via the diamine exporter. The actions of ibuprofen were not stereospecific, supporting previous studies that cyclooxygenase (COX) inhibition is unlikely to be involved in the ability of NSAIDs to reduce intracellular diamine levels.</p> <p>Conclusions</p> <p>Our data demonstrate that ibuprofen, a drug known to reduce the risk of colorectal cancer, reduces cellular diamine levels via augmentation of diamine efflux. Similarly, augmentation of membrane plasmalogens can increase diamine export from control and plasmalogen-deficient cells. These data support the concept that membrane transporter function may be a therapeutic point of intervention for dietary and pharmacological approaches to cancer chemoprevention.</p>
first_indexed 2024-12-21T07:01:17Z
format Article
id doaj.art-ccae4fb67654433983e80d9146f57d4a
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-12-21T07:01:17Z
publishDate 2011-11-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-ccae4fb67654433983e80d9146f57d4a2022-12-21T19:12:13ZengBMCLipids in Health and Disease1476-511X2011-11-0110121410.1186/1476-511X-10-214Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogensWood Paul LKhan MSmith TaraGoodenowe Dayan B<p>Abstract</p> <p>Background</p> <p>To develop effective strategies in cancer chemoprevention, an increased understanding of endogenous biochemical mediators that block metastatic processes is critically needed. Dietary lipids and non-steroidal anti-inflammatory drugs (NSAIDs) have a published track record of providing protection against gastrointestinal malignancies. In this regard, we examined the effects of membrane plasmalogens and ibuprofen on regulation of cellular levels of diamines, polyamine mediators that are augmented in cancer cells. For these studies we utilized Chinese hamster ovary (CHO) cells and NRel-4 cells, a CHO cell line with defective plasmalogen synthesis.</p> <p>Results</p> <p>NRel-4 cells, which possess cellular plasmalogen levels that are 10% of control CHO cells, demonstrated 2- to 3-fold increases in cellular diamine levels. These diamine levels were normalized by plasmalogen replacement and significantly reduced by ibuprofen. In both cases the mechanism of action appears to mainly involve increased diamine efflux via the diamine exporter. The actions of ibuprofen were not stereospecific, supporting previous studies that cyclooxygenase (COX) inhibition is unlikely to be involved in the ability of NSAIDs to reduce intracellular diamine levels.</p> <p>Conclusions</p> <p>Our data demonstrate that ibuprofen, a drug known to reduce the risk of colorectal cancer, reduces cellular diamine levels via augmentation of diamine efflux. Similarly, augmentation of membrane plasmalogens can increase diamine export from control and plasmalogen-deficient cells. These data support the concept that membrane transporter function may be a therapeutic point of intervention for dietary and pharmacological approaches to cancer chemoprevention.</p>http://www.lipidworld.com/content/10/1/214CHONRel-4ibuprofenplasmalogensomega-3 fatty acidsPPI-1011putrescinecadaverinediamine exporterornithine decarboxylasecancer chemoprevention
spellingShingle Wood Paul L
Khan M
Smith Tara
Goodenowe Dayan B
Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens
Lipids in Health and Disease
CHO
NRel-4
ibuprofen
plasmalogens
omega-3 fatty acids
PPI-1011
putrescine
cadaverine
diamine exporter
ornithine decarboxylase
cancer chemoprevention
title Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens
title_full Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens
title_fullStr Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens
title_full_unstemmed Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens
title_short Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens
title_sort cellular diamine levels in cancer chemoprevention modulation by ibuprofen and membrane plasmalogens
topic CHO
NRel-4
ibuprofen
plasmalogens
omega-3 fatty acids
PPI-1011
putrescine
cadaverine
diamine exporter
ornithine decarboxylase
cancer chemoprevention
url http://www.lipidworld.com/content/10/1/214
work_keys_str_mv AT woodpaull cellulardiaminelevelsincancerchemopreventionmodulationbyibuprofenandmembraneplasmalogens
AT khanm cellulardiaminelevelsincancerchemopreventionmodulationbyibuprofenandmembraneplasmalogens
AT smithtara cellulardiaminelevelsincancerchemopreventionmodulationbyibuprofenandmembraneplasmalogens
AT goodenowedayanb cellulardiaminelevelsincancerchemopreventionmodulationbyibuprofenandmembraneplasmalogens